Fundamentals of active specific immunotherapy of cancer using BCG-tumor cell vaccines
Hanna, M.G.; Peters, L.C.; Hoover, H.C.
Progress in Clinical and Biological Research 310: 51-65
1989
ISSN/ISBN: 0361-7742 PMID: 2672023 Document Number: 337058
Document emailed within 1 workday
Related Documents
Schirrmacher, V.; von Hoegen, P.; Heicappell, R. 1989: Virus modified tumor cell vaccines for active specific immunotherapy of micrometastases: expansion and activation of tumor-specific T cells Progress in Clinical and Biological Research 288: 391-399Grossmann, A.; Rameken, M.; Klapdor, R. 1997: Active-specific immunotherapy of pancreatic carcinoma: usefulness of human pancreatic carcinomas in preparing autologous tumor vaccines Anticancer Research 17(4b): 3117-3119
Castello, G.; D'Alessio, V. 1991: Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies La Clinica Terapeutica 137(3): 155-167
Tanaka, T.; Saito, T. 1975: Immunotherapy of cancer: induction of tumor immunity with a mixture of tumor cell-BCG, and the effect of intratumor injection of BCG and of nonliving BCG preparation Gan 66(6): 631-640
Raychaudhuri, S.; Saeki, Y.; Chen, J.J.; Iribe, H.; Fuji, H.; Kohler, H. 1987: Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta) Journal of Immunology 139(1): 271-278
Lotem, M.; Shiloni, E.; Ingber, A.; Peretz, T. 1997: Active specific immunotherapy of malignant melanoma Harefuah 133(3-4): 122-126
Mutzner, P.A.; Stuhlmiller, G.M.; Seigler, H.F.; Stumpf, W.E.; Sar, M. 1981: Basis for a specific-active immunotherapy in malignant melanoma Schweizerische Medizinische Wochenschrift 111(36): 1322-1325
Yang, S.C.; Owen-Schaub, L.; Mendiguren-Rodriguez, A.; Grimm, E.A.; Hong, W.K.; Roth, J.A. 1990: Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha Journal of Thoracic and Cardiovascular Surgery 99(1): 8
Minev, B.R.; Guo, F.; Gueorguieva, I.; Kaiser, H.E. 2002: Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects In Vivo 16(6): 405-415
Mocellin, S. 2005: Priming anticancer active specific immunotherapy with dendritic cells Current Opinion in Investigational Drugs 6(6): 576-581
Romodanov, S.A.; Zatula, D.G.; Lisianyĭ, N.I.; Glavatskiĭ, A.Ia.; Prosvirneva, G.M. 1986: Efficacy of experimental active specific immunotherapy and immunoprevention of malignant gliomas of the brain Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 1986(3): 18-23
Ashley, M.P.; Zbar, B.; Hunter, J.T.; Rapp, H.J.; Sugimoto, T. 1980: Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery Cancer Research 40(11): 4197-4203
Naito, K.; Pellis, N.R.; Kahan, B.D. 1988: Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide Cancer Research 48(1): 101-108
Guzmán-Rojas, L.; Alcocer-González, J.M.; Madrid-Marina, V. 1998: Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer Salud Publica de Mexico 40(1): 38-46
Thurnher, M.; Papesh, C.; Ramoner, R.; Gastl, G.; Böck, G.; Radmayr, C.; Klocker, H.; Bartsch, G. 1997: In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy Experimental Hematology 25(3): 232-237
2014: Modern cancer treatment by active immunotherapy Versicherungsmedizin 66(1): 48-49
Perek, Y.; Hurwitz, E.; Burowski, D.; Haimovich, J. 1983: Immunotherapy of a murine B cell tumor with antibodies and F(ab')2 fragments against idiotypic determinants of its cell surface IgM Journal of Immunology 131(3): 1600-1603
Matis, L.A.; Ruscetti, S.K.; Longo, D.L.; Jacobson, S.; Brown, E.J.; Zinn, S.; Kruisbeek, A.M. 1985: Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen Journal of Immunology 135(1): 703-713
Neagoe, G.; Stoian, M. 1986: Methods of active immunotherapy and viral oncolysis in some forms of cancer Medecine Interne 24(2): 125-142
Sheffer, A.L. 1993: Allergen-specific immunotherapy: a role for T-cell anergy Annals of Allergy 71(3): 327-329